Targeting a Novel ER/HOXB7 Signaling Loop in Tamoxifen-Resistant Breast Cancer

The majority of patients with breast cancer present with an estrogen receptor-positive (ER(+)) tumor, and the endocrine agent tamoxifen is a mainstay for their treatment. Unfortunately, however, resistance remains a major problem because most patients who respond eventually have a recurrence. Thus,...

Full description

Bibliographic Details

Published in:	Cancer discovery Vol. 5; no. 9; p. 909
Main Authors:	Heideman, Marinus R, Frei, Anna, Hynes, Nancy E
Format:	Journal Article
Language:	English
Published:	United States 01.09.2015
Subjects:	Animals Antineoplastic Agents, Hormonal - pharmacology Drug Resistance, Neoplasm - genetics Estrogen Receptor alpha - metabolism Female Gene Expression Regulation, Neoplastic Homeodomain Proteins - metabolism Humans Receptor, ErbB-2 - metabolism
ISSN:	2159-8290, 2159-8290
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!